News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
631,969 Results
Type
Article (60687)
Company Profile (79)
Press Release (571203)
Section
Business (173289)
Career Advice (2711)
Deals (32359)
Drug Delivery (87)
Drug Development (76604)
Employer Resources (148)
FDA (14839)
Job Trends (13832)
News (304104)
Policy (28851)
Tag
Academia (2869)
Alliances (42767)
Alzheimer's disease (1174)
Approvals (14784)
Artificial intelligence (132)
Bankruptcy (280)
Best Places to Work (10760)
Breast cancer (117)
Cancer (1067)
Cardiovascular disease (93)
Career advice (2293)
Cell therapy (237)
Clinical research (60797)
Collaboration (372)
Compensation (121)
COVID-19 (2514)
C-suite (106)
Cystic fibrosis (82)
Data (1110)
Diabetes (137)
Diagnostics (5929)
Earnings (58487)
Employer resources (131)
Events (91771)
Executive appointments (327)
FDA (15382)
Funding (346)
Gene therapy (174)
GLP-1 (546)
Government (4381)
Healthcare (18075)
Infectious disease (2590)
Inflammatory bowel disease (106)
Interviews (521)
IPO (14596)
Job creations (3408)
Job search strategy (1935)
Layoffs (440)
Legal (6380)
Lung cancer (162)
Manufacturing (163)
Medical device (12466)
Medtech (12471)
Mergers & acquisitions (17889)
Metabolic disorders (367)
Neuroscience (1437)
NextGen Class of 2024 (6356)
Non-profit (4300)
Northern California (1333)
Obesity (204)
Opinion (204)
Patents (104)
People (58475)
Phase I (19066)
Phase II (26842)
Phase III (19603)
Pipeline (442)
Postmarket research (2464)
Preclinical (8142)
Radiopharmaceuticals (239)
Rare diseases (214)
Real estate (5965)
Regulatory (19350)
Research institute (2383)
Resumes & cover letters (405)
Southern California (1189)
Startups (3327)
United States (12260)
Vaccines (532)
Weight loss (147)
Date
Today (128)
Last 7 days (666)
Last 30 days (3324)
Last 365 days (32710)
2024 (29998)
2023 (36332)
2022 (46615)
2021 (51569)
2020 (50718)
2019 (44762)
2018 (34054)
2017 (30710)
2016 (30053)
2015 (35436)
2014 (28372)
2013 (24943)
2012 (26204)
2011 (26448)
2010 (24922)
Location
Africa (866)
Arizona (136)
Asia (37359)
Australia (6723)
California (2966)
Canada (1172)
China (231)
Colorado (141)
Connecticut (143)
Europe (86817)
Florida (430)
Georgia (115)
Illinois (355)
Indiana (172)
Kansas (87)
Maryland (535)
Massachusetts (2211)
Michigan (159)
Minnesota (228)
New Jersey (898)
New York (872)
North Carolina (728)
Northern California (1333)
Ohio (130)
Pennsylvania (754)
South America (1172)
Southern California (1189)
Texas (439)
Utah (89)
Washington State (325)
631,969 Results for "university of verona".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
June 26, 2024
·
10 min read
Press Releases
Verona Pharma Announces December 2024 Investor Conference Participation
November 19, 2024
·
1 min read
Press Releases
Verona Pharma to Present at Jefferies London Healthcare Conference 2024
November 5, 2024
·
1 min read
Bio NC
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
Verona Pharma plc, announces it and its wholly-owned subsidiary, Verona Pharma, Inc., have entered into strategic financing agreements providing access to up to $650 million from funds managed by Oaktree Capital Management, L.P. and OMERS Life Sciences.
May 9, 2024
·
10 min read
Press Releases
Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 4, 2024
·
8 min read
FDA
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout
Verona Pharma on Wednesday secured the FDA’s approval for Ohtuvayre, which the company contends is the first inhaled chronic obstructive pulmonary disease medicine with a new mechanism of action in over 20 years.
June 27, 2024
·
2 min read
·
Tristan Manalac
Business
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
Verona Pharma plc announces its financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
14 min read
Business
Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Verona Pharma plc has received approval from the U.S. Food and Drug Administration (FDA) for Ohtuvayre™ (ensifentrine).
June 27, 2024
·
6 min read
Press Releases
Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update
October 21, 2024
·
1 min read
Business
Andrew Fisher Joins Verona Pharma as General Counsel
Verona Pharma plc, announces Mr. Andrew Fisher has joined the Company as General Counsel, and member of the Executive Management Team.
March 4, 2024
·
4 min read
1 of 63,197
Next
